Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 3:30 AM UTC
| NCT Number | NCT07214779 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE3 |
| Target Enrollment | 466 participants |
| Active Locations | 48 sites in the US |
| Sponsor | Incyte Corporation |
| Last Updated on CT.gov | August 6, 2026 (3 weeks ago) |
As of August 29, 2026: Clinical trial NCT07214779 is currently recruiting participants. This phase3 study for ovarian cancer is actively seeking new participants at 48 locations across the United States. The study is sponsored by Incyte Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07214779 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 48 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07214779 was last updated 3 weeks ago (August 6, 2026). HelloStudys verifies this status automatically.